PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hackensack Meridian Health Center for Discovery and Innovation, Nutley, New Jersey, USA.\', \'Avalo Therapeutics, Wayne, Pennsylvania, USA.\', \'Laboratory of Molecular Immunology, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/JCI153173e153173
?:doi
?:hasPublicationType
?:journal
  • The Journal of clinical investigation
is ?:pmid of
?:pmid
?:pmid
  • 34871182
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34871182>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34871182>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all